- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06092359
The Eye in Orbit: UCF Adaption
December 3, 2024 updated by: University of Central Florida
The Eye in Orbit- Analysis of the Anatomical and Functional Ocular Changes Related to Space Flights: UCF Adaptation.
The goal of this study is to understand the impact of space travel on the eyes.
Space flight impacts numerous aspects of ocular anatomy and physiology.
Current hypotheses are based on pressure changes within and around the optic nerve.
Retinal and choroid blood drainage may be affected by microgravity associated cerebrospinal fluid pressure changes.
Recently, a new imaging modality, Optical Coherence Tomography Angiography (OCTA), has been able to reveal micro vascular changes in the retina and choroid.
To date, no microgravity ocular imaging tests have been published using OCTA.
In this study the researchers aim to describe microgravity circadian choroidal and retinal vasculature using multimodal imaging including OCTA to better understand space associated ocular changes.
Study Overview
Status
Completed
Conditions
Study Type
Observational
Enrollment (Actual)
1
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Florida
-
Orlando, Florida, United States, 32816
- University of Central Florida
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Sampling Method
Non-Probability Sample
Study Population
This study necessarily had a very specific population.
The study only enrolled astronauts in the AX1/Rakia mission, which was scheduled for space flight in late March 2022.
Description
Inclusion Criteria:
- astronauts in the AX1/Rakia mission, which was scheduled for space flight in late March 2022.
Exclusion Criteria:
- adults unable to consent
- individuals who are not yet adults (infants, children, teenagers) -
- pregnant women
- prisoners.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
To examine early changes in ocular physiology following exposure to microgravity and asses these changes as risk factor for Spaceflight Associated Neuro-Ocular Syndrome (SANS).
Time Frame: 4 months
|
4 months
|
|
Asses early changes in ocular physiology as risk factor for Spaceflight Associated Neuro-Ocular Syndrome (SANS).
Time Frame: 4 months
|
4 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Mehul Patel, MD, MSc, University of Central Florida
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
March 1, 2022
Primary Completion (Actual)
July 31, 2022
Study Completion (Actual)
July 31, 2022
Study Registration Dates
First Submitted
October 9, 2023
First Submitted That Met QC Criteria
October 17, 2023
First Posted (Actual)
October 23, 2023
Study Record Updates
Last Update Posted (Estimated)
December 6, 2024
Last Update Submitted That Met QC Criteria
December 3, 2024
Last Verified
December 1, 2024
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- STUDY00003845
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Spaceflight Associated Neuro-Ocular Syndrome
-
University of Texas Southwestern Medical CenterCompletedSpace Flight Associated Neuro-ocular SyndromeUnited States
-
IRCCS Azienda Ospedaliero-Universitaria di BolognaUniversity of BolognaCompletedGlaucoma | Neuro-Degenerative DiseaseItaly
-
Centre Hospitalier National d'Ophtalmologie des...RecruitingGlaucoma Associated With Other Ocular DisordersFrance
-
University of ZurichUSZ FoundationActive, not recruiting
-
Alcon ResearchCompletedOcular Inflammation Associated With BlepharaconjunctivitisUnited States
-
Sun Pharma Advanced Research Company LimitedCompletedInflammation and Pain Associated With Ocular SurgeryUnited States
-
University of GaziantepCompletedCOVID-19-Associated Acute Respiratory Distress Syndrome (ARDS)Turkey (Türkiye)
-
Silverstein Eye CentersBausch & Lomb Incorporated; Churchhill Communications; Statistics & Data CorporationCompletedTreatment of Ocular Inflammation Associated With Cataract Surgery
-
Sidney Kimmel Comprehensive Cancer Center at Johns...Incyte CorporationNot yet recruitingImmune Effector Associated Hemophagocytic Lymphohistiocytosis-like Syndrome (IEC-HS)
-
Beijing Friendship HospitalUnknownOcular Ischemia SyndromeChina